CDC34, which is upregulated in B-ALL EVs, is known to facilitate lung cancer progression (84), while NUF2, which is upregulated in the EVs of 6 of 8 B-ALL samples in this study, is known to facilitate the progression of lung adenocarcinoma (85). Here, NUF2 is linked to lung carcinoma.